Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Smith Micro Software
SMSI
$15.7M
| $1.06M | ﹤0.01% |
21,908
+6,845
| +45% | +$359K |
|
2252
Babcock & Wilcox
BW
$1.4B
| $1.06M | ﹤0.01% |
251,438
+156,130
| +164% | +$815K |
|
2253
BayCom
BCML
$335M
| $1.06M | ﹤0.01% |
55,000
+4,800
| +10% | +$90.8K |
|
2254
Kura Oncology
KURA
$824M
| $1.05M | ﹤0.01% |
115,600
-72,500
| -39% | -$736K |
|
2255
iShares MSCI Indonesia ETF
EIDO
$489M
| $1.05M | ﹤0.01% |
+47,300
| New | +$1.09M |
|
2256
Sutro Biopharma
STRO
$400M
| $1.05M | ﹤0.01% |
30,290
+3,340
| +12% | +$146K |
|
2257
Cumberland Pharmaceuticals
CPIX
$115M
| $1.05M | ﹤0.01% |
555,763
-4,980
| -0.9% | -$8.35K |
|
|
NWLI
2258
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $1.05M | ﹤0.01% |
2,400
-300
| -11% | -$132K |
|
2259
IRIDEX
IRIX
$14.6M
| $1.05M | ﹤0.01% |
413,060
-6,100
| -1% | -$11.6K |
|
|
LX
2260
LexinFintech Holdings
LX
$239M
| $1.05M | ﹤0.01% |
473,674
+199,777
| +73% | +$482K |
|
|
ITI
2261
DELISTED
Iteris, Inc.
ITI
| $1.05M | ﹤0.01% |
252,785
+25,100
| +11% | +$107K |
|
|
MPX
2262
DELISTED
Marine Products Corp
MPX
| $1.05M | ﹤0.01% |
73,602
+11,500
| +19% | +$180K |
|
2263
Lifestance Health
LFST
$4.07B
| $1.04M | ﹤0.01% |
152,000
+100,178
| +193% | +$812K |
|
2264
Huntsman Corp
HUN
$1.78B
| $1.04M | ﹤0.01% |
42,700
-176,000
| -80% | -$4.77M |
|
2265
Mastech Digital
MHH
$95.7M
| $1.04M | ﹤0.01% |
115,727
-16,100
| -12% | -$167K |
|
2266
Peoples Financial Services
PFIS
$716M
| $1.04M | ﹤0.01% |
25,981
+700
| +3% | +$31.4K |
|
2267
Avita Medical
RCEL
$146M
| $1.04M | ﹤0.01% |
71,200
-28,800
| -29% | -$487K |
|
2268
Avantis US Small Cap Value ETF
AVUV
$30.7B
| $1.04M | ﹤0.01% |
13,300
-900
| -6% | -$72.3K |
|
|
SBDS
2269
DELISTED
Solo Brands Inc
SBDS
| $1.04M | ﹤0.01% |
5,078
-1,895
| -27% | -$413K |
|
|
APLT
2270
DELISTED
Applied Therapeutics
APLT
| $1.03M | ﹤0.01% |
415,478
+8,100
| +2% | +$13.4K |
|
2271
Flexible Solutions
FSI
$64.2M
| $1.03M | ﹤0.01% |
380,245
-12,800
| -3% | -$34.8K |
|
2272
VanEck Vietnam ETF
VNM
$504M
| $1.03M | ﹤0.01% |
76,200
-62,400
| -45% | -$908K |
|
2273
Protalix BioTherapeutics
PLX
$197M
| $1.03M | ﹤0.01% |
621,100
-38,200
| -6% | -$68.6K |
|
2274
Community Bank
CBU
$3.44B
| $1.03M | ﹤0.01% |
+24,408
| New | +$1.16M |
|
|
ALYA
2275
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $1.03M | ﹤0.01% |
681,133
-5,100
| -0.7% | -$9.12K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.